Literature DB >> 14685072

Acid secretion from birth to adulthood.

John T Boyle1.   

Abstract

All infants, including premature infants as young as 24 weeks' gestational age, are able to maintain an intragastric pH below 4 from the first day of life. By 24 weeks, maximal acid output approaches that in adults. In adult studies, proton pump inhibitors (PPIs) are highly effective in relieving reflux symptoms and healing reflux esophagitis. Studies are needed to evaluate PPI efficacy and appropriate dosing in infants and children. Consequences such as hypergastrinemia, bacterial overgrowth, and other potential adverse events associated with long-term PPI use also warrant evaluation in the pediatric population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14685072     DOI: 10.1097/00005176-200311001-00004

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  10 in total

Review 1.  Optimizing the Use of Medications and Other Therapies in Infant Gastroesophageal Reflux.

Authors:  Steven L Ciciora; Frederick W Woodley
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

2.  Feeding intolerance in preterm infants fed with powdered or liquid formula: a randomized controlled, double-blind, pilot study.

Authors:  Ozge Surmeli-Onay; Ayse Korkmaz; Sule Yigit; Murat Yurdakok
Journal:  Eur J Pediatr       Date:  2013-01-05       Impact factor: 3.183

3.  Development of Pediatric Dosage Preparation for CVD 103-HgR Live Oral Cholera Vaccine.

Authors:  R Paul Duffin; Michael Delbuono; Kylie Nishioka; Paul Shabram; Amish A Patel
Journal:  Am J Trop Med Hyg       Date:  2022-07-05       Impact factor: 3.707

Review 4.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

5.  Population pharmacokinetics of rabeprazole and dosing recommendations for the treatment of gastroesophageal reflux disease in children aged 1-11 years.

Authors:  Sarah C McLeay; Bruce Green; William Treem; An Thyssen; Erik Mannaert; Holly Kimko
Journal:  Clin Pharmacokinet       Date:  2014-10       Impact factor: 6.447

Review 6.  Pharmacokinetics of intravenous omeprazole in critically ill paediatric patients.

Authors:  Maria Jose Solana; Jesús López-Herce
Journal:  Eur J Clin Pharmacol       Date:  2009-12-30       Impact factor: 2.953

7.  Dose-Finding Study of Omeprazole on Gastric pH in Neonates with Gastro-Esophageal Acid Reflux Using a Bayesian Sequential Approach.

Authors:  Florentia Kaguelidou; Corinne Alberti; Valerie Biran; Olivier Bourdon; Caroline Farnoux; Sarah Zohar; Evelyne Jacqz-Aigrain
Journal:  PLoS One       Date:  2016-12-21       Impact factor: 3.240

8.  Nutrigenomics-Associated Impacts of Nutrients on Genes and Enzymes With Special Consideration of Aromatase.

Authors:  Helena Jenzer; Leila Sadeghi-Reeves
Journal:  Front Nutr       Date:  2020-04-09

Review 9.  Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics.

Authors:  Robert M Ward; Gregory L Kearns
Journal:  Paediatr Drugs       Date:  2013-04       Impact factor: 3.022

10.  Use of pH reagent strips to verify gastric tube placement in newborns.

Authors:  Flávia de Souza Barbosa Dias; Beatriz Pera de Almeida; Beatriz Regina Alvares; Rodrigo Menezes Jales; Jamil Pedro de Siqueira Caldas; Elenice Valentim Carmona
Journal:  Rev Lat Am Enfermagem       Date:  2019-12-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.